Renaissance Capital logo

Co-Diagnostics

Priced, Nasdaq: CODX

Commercializing diagnostic equipment for DNA tests.

Industry: Health Care

First Day Return: -3.2%

Co-Diagnostics is a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), and to sell diagnostic equipment from other manufacturers as self-contained lab systems. We will either sell or lease our portable labs to existing diagnostic centers, through sale or lease agreements, and sell the reagents that comprise our proprietary tests.
IPO Data
IPO Date 07/12/2017
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $7
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Salt Lake City, UT, United States
Founded 2013
Employees at IPO 12
Website www.codiagnostics.com

Co-Diagnostics (CODX) Performance